IDO1 and breast cancer: Notably, high Pyk2 expression in triple‐negative breast cancer (TNBC) was strongly correlated with lymph node metastasis and poor outcomes.[49] Here, we showed that the expression of IDO1 and Pyk2 phosphorylation were positively correlated in patients with breast cancer.